TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.868
+0.050 (6.14%)
At close: Feb 27, 2026, 4:00 PM EST
0.826
-0.043 (-4.90%)
After-hours: Feb 27, 2026, 5:25 PM EST
TELA Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for TELA Bio stock have an average target of 3.31, with a low estimate of 1.25 and a high estimate of 5.00. The average target predicts an increase of 281.29% from the current stock price of 0.87.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 1, 2025.
Analyst Ratings
The average analyst rating for TELA Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | +245.58% | Dec 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $4 | Strong Buy | Maintains | $7 → $4 | +360.78% | Nov 18, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 → $1.25 | Hold | Reiterates | $2 → $1.25 | +43.99% | Nov 14, 2025 |
| Citizens | Citizens | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +475.97% | Nov 14, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $7 | Strong Buy | Maintains | $12 → $7 | +706.36% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
82.06M
from 69.30M
Increased by 18.41%
Revenue Next Year
94.53M
from 82.06M
Increased by 15.20%
EPS This Year
-0.85
from -1.33
EPS Next Year
-0.60
from -0.85
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 84.5M | 97.7M | ||
| Avg | 82.1M | 94.5M | ||
| Low | 78.8M | 90.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 22.0% | 19.0% | ||
| Avg | 18.4% | 15.2% | ||
| Low | 13.7% | 10.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.85 | -0.52 | ||
| Avg | -0.85 | -0.60 | ||
| Low | -0.83 | -0.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.